BARNETT INTERNATIONAL ANNOUNCES FALL SEMESTER OF CLINICAL RESEARCH TRAINING PROGRAMS
PHILADELPHIA, PA, June 12, 2000 — Barnett International Corporation, a subsidiary of PAREXEL International Corporation (Nasdaq:PRXL), announced today a new semester of clinical research training programs being offered at the following universities: Villanova University, Rutgers University, Georgetown University, University of North Carolina, Northwestern University, Boston College, University of San Diego and a five day program at the Mountain Area Health Education in Asheville, NC. The programs are titled “Developing Clinical Data Management Skills”, “Developing Clinical Research Associate Skills” and “Developing Clinical Research Coordinator Skills”. The curriculum is designed to offer new career opportunities in for healthcare professionals in clinical research. The courses begin between September 5 and October 28, 2000 and last for 6-12 weeks depending on the university.
According to the latest data from the U.S. Department of Labor, the demand for qualified Clinical Research Associates, Clinical Research Coordinators, and Clinical Data Managers is expected to nearly double over the next ten years. Barnett offers these new courses in response to the industry’s growing need for such professionals.
The “Developing Clinical Data Management Skills” program helps pharmaceutical industry employees responsible for reviewing clinical data generated in investigational drug trials. The course covers coding the data for database entry, editing the data for accuracy and completeness, and finalizing the data for statistical analysis and review. “Developing Clinical Research Associate Skills” is geared to professionals who monitor clinical investigations of experimental drugs and medical devices for pharmaceutical/biotechnical and medical device manufacturers. The “Developing Clinical Research Coordinator Skills” program reviews and discusses the Clinical Research Coordinator’s (CRC) role in the day-to-day management of clinical trials and the CRC’s close working relationships with the investigating physician and study sponsor.
Barnett International is a recognized industry leader in pharmaceutical consulting, education and training, specializing in such areas as technology, performance benchmarking, clinical training, knowledge management, industry conferences, and the publication of drug development texts and journals.
This release may contain "forward-looking" statements regarding future results and events, including statements regarding expected future growth and customer demand. The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release. Important factors that might cause such a difference include, but are not limited to, risks associated with: the cancellation or delay of contracts; the Company's dependence on certain industries and clients; the Company's ability to manage growth and its ability to attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses; government regulation of certain industries and clients; competition and consolidation within the pharmaceutical industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations. These factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2000.
PAREXEL is one of the largest contract pharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that accelerate time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. The Company’s integrated services, therapeutic area depth and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths. Headquartered near Boston, MA, PAREXEL operates in 43 locations throughout 29 countries around the world, and has approximately 4,275 employees.